Edition:
United Kingdom

Marrone Bio Innovations Inc (MBII.OQ)

MBII.OQ on NASDAQ Stock Exchange Capital Market

1.23USD
16 Feb 2018
Change (% chg)

$0.01 (+0.82%)
Prev Close
$1.22
Open
$1.26
Day's High
$1.27
Day's Low
$1.15
Volume
35,145
Avg. Vol
23,477
52-wk High
$2.30
52-wk Low
$0.85

Latest Key Developments (Source: Significant Developments)

Marrone Bio Innovations ‍Signs Exclusive Distribution Agreement With Great Harvest Agri Chemicals Corp
Thursday, 25 Jan 2018 

Jan 25 (Reuters) - Marrone Bio Innovations Inc ::MARRONE BIO INNOVATIONS INC - ‍SIGNED AN EXCLUSIVE DISTRIBUTION AGREEMENT WITH GREAT HARVEST AGRI CHEMICALS CORPORATION​.  Full Article

Marrone Bio Innovations, Inc. Announces Comprehensive Financing And Debt Restructuring Transaction
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Marrone Bio Innovations Inc ::MARRONE BIO INNOVATIONS, INC. ANNOUNCES COMPREHENSIVE FINANCING AND DEBT RESTRUCTURING TRANSACTION.MARRONE BIO INNOVATIONS-EACH OF 30.7 MILLION UNITS BEING BOUGHT BY OSPRAIE TO HAVE OF A SHARE OF CO, & A WARRANT TO BUY ONE SHARE FOR $1.00/SHARE.MARRONE BIO INNOVATIONS - EACH OF 13.3 MILLION UNITS BEING BOUGHT BY OTHER BUYERS TO HAVE 1 SHARE & A WARRANT TO BUY 0.8 SHARES OF CO FOR $1.00/SHARE.MARRONE BIO - INTENDS TO APPOINT TWO NEW CLASS I DIRECTORS DESIGNATED BY OSPRAIE TO CO'S BOARD OF DIRECTORS, EFFECTIVE UPON CLOSING.MARRONE BIO INNOVATIONS INC - EXPECTS TO RECEIVE APPROXIMATELY $27.7 MILLION OF CASH NET PROCEEDS FROM PROPOSED TRANSACTIONS.MARRONE BIO INNOVATIONS INC - CO'S OUTSTANDING INDEBTEDNESS EXPECTED TO BE REDUCED FROM $62.5 MILLION TO $17.5 MILLION FROM DEBT RESTRUCTURING​.MARRONE BIO INNOVATIONS INC - INTEREST RATE UNDER SNYDER LOAN AGREEMENT HAS ALSO BEEN REDUCED FROM 14% TO 8%.  Full Article

Marrone Bio Innovations qtrly ‍basic, diluted net loss per common share $0.27​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Marrone Bio Innovations Inc ::Marrone Bio Innovations, Inc reports third quarter 2017 financial results.Q3 revenue rose 16 percent to $4.2 million.Marrone Bio Innovations Inc - qtrly ‍basic and diluted net loss per common share $0.27​.  Full Article

Marrone Bio Innovations receives EPA approval for novel biofungicide
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Marrone Bio Innovations Inc ::Marrone Bio Innovations receives EPA approval for novel biofungicide.Marrone Bio Innovations Inc - ‍received approval from U.S. Environmental Protection Agency on its newest biological fungicide, Stargus​.Marrone Bio Innovations Inc - ‍MBI expects first sales when state registrations are granted​.Marrone Bio Innovations - biofungicide has been submitted to Canada, Mexico for approval & dossier is being prepared for Europe.  Full Article

Marrone Bio signs exclusive agreement with Kenya Biologics
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Marrone Bio Innovations Inc :Marrone Bio Innovations signs exclusive distribution agreement with Kenya Biologics Ltd. For Kenya and Tanzania.Marrone Bio Innovations Inc - ‍ signed exclusive distribution agreement with Kenya Biologics Ltd to bring MBI's biopesticides to Kenya and Tanzania​.  Full Article

Marrone Bio files for mixed shelf of up to $50 million
Friday, 9 Dec 2016 

Marrone Bio Innovations Inc :Marrone Bio Innovations - files for mixed shelf of up to $50 million.  Full Article

Marrone Bio says Mexico regulatory authorities approve GRANDEVO, VENERATE for sale
Tuesday, 26 Jul 2016 

Marrone Bio Innovations Inc :Mexico regulatory authorities have approved for sale both of company's bioinsecticides, grandevo and venerate.  Full Article

Marrone Bio says lenders waive $15 mln minimum cash balance requirement
Thursday, 2 Jun 2016 

Marrone Bio Innovations Inc : On May 31, entered into an amendment to its senior secured promissory notes, dated August 20, 2015 - sec filing .Investors agreed to delete from notes provisions that had required company to maintain a $15 million minimum cash balance.  Full Article

Marrone Bio says agreed to settle class action litigation
Thursday, 26 May 2016 

Marrone Bio Innovations Inc : Agreement provides for a settlement payment to class of $12 million . Payment will be paid by insurance carriers .Marrone Bio Innovations announces agreement to settle class action litigation.  Full Article

Marrone Bio Innovations reports Q1 net loss $9.3 million
Thursday, 12 May 2016 

Marrone Bio Innovations Inc : Says net loss for Q1 of 2016 was $9.3 million, compared to a loss of $11.9 million in Q1 of 2015 .Q1 revenue $2.7 million versus $2.1 million.  Full Article

BRIEF-Marrone Bio Innovations Says ‍Board Approved An Increase In Size Of Board To Seven People

* MARRONE BIO INNOVATIONS SAYS ‍ BOARD APPROVED AN INCREASE IN SIZE OF BOARD TO SEVEN PEOPLE - SEC FILING​ Source text: [http://bit.ly/2EthyhL] Further company coverage: